Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 154 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: U54 NS115054
NIGMS NIH HHS
Grant: T32 GM007205
NIAID NIH HHS
Grant: R01 AI114780
NIAID NIH HHS
Grant: R21 AI142198
National Institutes of Health
Muscular Dystrophy Association
FWCI
5.36
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients
Additional file 2 of Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients
Additional file 1 of Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
Additional file 1 of Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy